Form 8-K - Current report:
SEC Accession No. 0001193125-24-213595
Filing Date
2024-09-05
Accepted
2024-09-05 06:02:55
Documents
13
Period of Report
2024-09-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d817794d8k.htm   iXBRL 8-K 22160
  Complete submission text file 0001193125-24-213595.txt   147488

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bior-20240905.xsd EX-101.SCH 2867
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20240905_lab.xml EX-101.LAB 18736
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20240905_pre.xml EX-101.PRE 11718
15 EXTRACTED XBRL INSTANCE DOCUMENT d817794d8k_htm.xml XML 3778
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 241279754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)